Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Anti-PF4/Heparin Antibody Levels in Bacteremia, Fungemia and Sepsis

Satish Maharaj, MBBS, Simone Chang, MBBS, Karan Seegobin, MBBS, Fauzia Rana, MD, Marwan Shaikh, MD

Blood (2018) 132 (Supplement 1): 3752.

https://doi.org/10.1182/blood-2018-99-117917

Published: 2018

Journal Articles

Mucocutaneous Engraftment and Type VII Collagen (C7) Replacement after Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Jakub Tolar, MD, PhD, John A McGrath, MD, Mark J. Osborn, PhD, Douglas R Keene, BS, Kristen Hook, MD, Maria Hordinsky, MD, David Woodley, MD, Mei Chen, PhD, Alain Hovnanian, MD PhD, Katsuto Tamai, MD PhD, Bruce R. Blazar, MD, John E Wagner, MD

Blood (2015) 126 (23): 402.

https://doi.org/10.1182/blood.V126.23.402.402

Published: 2015

Journal Articles

Successful Haploidentical Hematopoietic Stem Cell Transplant for GATA2 Deficiency

Christa S. Zerbe, MD, Jennifer Cuellar-Rodriguez, MD, Juan Gea-Banacloche, MD, Steven M. Holland, MD, Dennis D. Hickstein, MD

Blood (2014) 124 (21): 5838.

https://doi.org/10.1182/blood.V124.21.5838.5838

Published: 2014

Journal Articles

Final Results from a Phase 4 Open-Label 3-Year Study Evaluating Changes in Bone Marrow (Bm) Morphology in Adult Immune Thrombocytopenia (ITP) Patients (Pts) Receiving the Thrombopoietin Mimetic Romiplostim

Ann Janssens, Francesco Rodeghiero, David Anderson, Beng Chong, Zoltan Boda, Ingrid Pabinger, Libor Cervinek, MD PhD, Xuena Wang, Angela Lopez

Blood (2014) 124 (21): 2774.

https://doi.org/10.1182/blood.V124.21.2774.2774

Published: 2014

Journal Articles

Results From a Phase IV Open-Label Study Evaluating Changes In Bone Marrow Morphology In Adult Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim: Analysis Of The 1- and 2-Year Romiplostim Cohorts

Ann Janssens, MD, Francesco Rodeghiero, David Anderson, Beng Chong, MBBS FRCPA FRACP PhD, Zoltan Boda, Ingrid Pabinger, Libor Cervinek, Xuena Wang, Angela Lopez

Blood (2013) 122 (21): 2312.

https://doi.org/10.1182/blood.V122.21.2312.2312

Published: 2013

Journal Articles

Adolescents and Young Adults With Hemophagocytic Lymphohistiocytosis Who Undergo Allogeneic Hematopoietic Cell Transplantation Are At Increased Risk Of Mortality Compared To Younger Patients

Shanmuganathan Chandrakasan, MD, Rebecca Marsh, MD, Michael Grimley, MD, Jack Bleesing, MD, PhD, Michael Jordan, MD, Alexandra H. Filipovich, MD

Blood (2013) 122 (21): 2087.

https://doi.org/10.1182/blood.V122.21.2087.2087

Published: 2013

Journal Articles

RAD001: A Clinico-Biological Phase I GOELAMS trial of Everolimus Association with High Dose Chemotherapy in Late Relapsing AML Patients Under 65 Years of Age

Sophie Park, Nicolas Chapuis, Franck Saint Marcoux, PharmD, PhD, Christian Recher, MD, PhD, Norbert Vey, MD, Thomas Prebet, MD, PhD, Patrice Chevallier, MD, Jean-Yves Cahn, MD, Arnaud Pigneux, MD, PhD, Bruno Lioure, Francis Witz, MD, Thierry Lamy, MD, PhD, Annabelle Merlat, Roselyne Delepine, Francois Dreyfus, Marie-christine Béné, Norbert Ifrah, Didier Bouscary, MD, PhD

Blood (2011) 118 (21): 945.

https://doi.org/10.1182/blood.V118.21.945.945

Published: 2011

Journal Articles

A Pilot Study of Reduced Toxicity Conditioning (RTC) with Busulfan (Bu), Fludarabine (Flu), and Alemtuzumab Followed by Allogeneic Stem Cell Transplantation (AlloSCT) to Induce Sustained Mixed Donor Chimerism In Patients with Symptomatic Sickle Cell Disease (SCD)

Monica Bhatia, MD, Mark B Geyer, AB, Courtney Baker, RN, MSN, PNP, Erin Morris, RN, BSN, Deirdre Duffy, BS, Diane George, MD, James H Garvin, Jr., MD, PhD, Prakash Satwani, MD, Joseph Schwartz, MD, Sandra Foley, CPNP, Ria Hawks, CPNP, Elana Hamburger-Smilow, CPNP, Lee Ann Baxter-Lowe, PhD, Mitchell S. Cairo, MD

Blood (2010) 116 (21): 3504.

https://doi.org/10.1182/blood.V116.21.3504.3504

Published: 2010

Journal Articles

Human Heme Oxygenase-1 Deficiency Presenting with Hemolysis, Bleeding, Nephritis, Asplenia and Inflammation.

Nita Radhakrishnan, MD, Satya Prakash Yadav, DCH, DNB, Anupam Sachdeva, DCH, MD, Taizo Wada, MD, PhD, Akihiro Yachie, MD, PhD

Blood (2009) 114 (22): 3013.

https://doi.org/10.1182/blood.V114.22.3013.3013

Published: 2009

Journal Articles

Clofarabine-Induced Remission in Relapsed Pediatric Acute Myelogenous Leukemia

Catherine Gordon, MD, Amanda Ledbetter, Gail Megason, MD

Blood (2008) 112 (11): 4042.

https://doi.org/10.1182/blood.V112.11.4042.4042

Published: 2008

Journal Articles

Hematopoietic Progenitor Cell Transplantation from Parental Donors for Children with Sickle Cell Anemia and Stroke.

Paul Woodard, MD, Gregory Hale, MD, Wing Leung, MD, PhD, Raymond Barfield, MD, PhD, Kimberly Kasow, DO, Renee Madden, MD, Rupert Handgretinger, MD, PhD, John Cunningham, MD, Russell Ware, MD, PhD

Blood (2007) 110 (11): 3393.

https://doi.org/10.1182/blood.V110.11.3393.3393

Published: 2007

Journal Articles

Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukaemia: Local Results of Modern Transplant Practice.

Jason P. Butler, MBBS, Glen A. Kennedy, MBBS, Geoff R. Hill, MD, James Morton, MBBS, Robyn Western, BN, Cheryl Hutchins, PhD, Simon Durrant, MBBS

Blood (2006) 108 (11): 5393.

https://doi.org/10.1182/blood.V108.11.5393.5393

Published: 2006

Journal Articles

Outcomes of Patients with Hematological Malignancies Admitted to Critical Care.

Girish Ravindranathan, MRCP, Vaia Grigoriadou, MRCP, Radovan Saso, MD, PhD, Shelley Dolan, MSc, PhD, Mark Ethell, MRCP, MRCPath, Michael Potter, FRCP, FRCPath, Jennifer Treleaven, FRCP, FRCPath, Gareth Morgan, FRCP, FRCPath

Blood (2006) 108 (11): 5289.

https://doi.org/10.1182/blood.V108.11.5289.5289

Published: 2006

Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

R. Gregory Bociek, MD, MSc, James E. Talmadge, PhD, James C. Lynch, PhD, Charles A. Enke, MD, Charles A. Kuszynski, PhD, Philip J. Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Timothy R. McGuire, PhD, James L. Wisecarver, MD, Shantaram S. Joshi, PhD, Zivko S. Pavletic, MD

Blood (2005) 106 (11): 3671.

https://doi.org/10.1182/blood.V106.11.3671.3671

Published: 2005

Journal Articles

Outcome of the Rotterdam-84 CNS-ALL Chemotherapy Protocol without Radiotherapy for Isolated Central Nervous System Relapsed Acute Lymphoblastic Leukemia.

Auke Beishuizen, MD, PhD, Femke K. Aarsen, MA, Jeanette E.W.M. van Dongen, PhD, MA, Isabelle C. Streng, MA, Rob Pieters, MD, PhD, Karel Hahlen, MD, PhD

Blood (2004) 104 (11): 1955.

https://doi.org/10.1182/blood.V104.11.1955.1955

Published: 2004

NARROW

Anti-PF4/Heparin Antibody Levels in Bacteremia, Fungemia and Sepsis

Mucocutaneous Engraftment and Type VII Collagen (C7) Replacement after Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Successful Haploidentical Hematopoietic Stem Cell Transplant for GATA2 Deficiency

Final Results from a Phase 4 Open-Label 3-Year Study Evaluating Changes in Bone Marrow (Bm) Morphology in Adult Immune Thrombocytopenia (ITP) Patients (Pts) Receiving the Thrombopoietin Mimetic Romiplostim

Results From a Phase IV Open-Label Study Evaluating Changes In Bone Marrow Morphology In Adult Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim: Analysis Of The 1- and 2-Year Romiplostim Cohorts

Adolescents and Young Adults With Hemophagocytic Lymphohistiocytosis Who Undergo Allogeneic Hematopoietic Cell Transplantation Are At Increased Risk Of Mortality Compared To Younger Patients

RAD001: A Clinico-Biological Phase I GOELAMS trial of Everolimus Association with High Dose Chemotherapy in Late Relapsing AML Patients Under 65 Years of Age

A Pilot Study of Reduced Toxicity Conditioning (RTC) with Busulfan (Bu), Fludarabine (Flu), and Alemtuzumab Followed by Allogeneic Stem Cell Transplantation (AlloSCT) to Induce Sustained Mixed Donor Chimerism In Patients with Symptomatic Sickle Cell Disease (SCD)

Human Heme Oxygenase-1 Deficiency Presenting with Hemolysis, Bleeding, Nephritis, Asplenia and Inflammation.

Clofarabine-Induced Remission in Relapsed Pediatric Acute Myelogenous Leukemia

Hematopoietic Progenitor Cell Transplantation from Parental Donors for Children with Sickle Cell Anemia and Stroke.

Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukaemia: Local Results of Modern Transplant Practice.

Outcomes of Patients with Hematological Malignancies Admitted to Critical Care.

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

Outcome of the Rotterdam-84 CNS-ALL Chemotherapy Protocol without Radiotherapy for Isolated Central Nervous System Relapsed Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only